“…A total of 12,018 persons with T2DM were included, of whom 5,893 were in the intervention group (IG) and 6,125 in the control group (CG), with an average age of 59.88 years (59.76 and 60, respectively). The mean baseline HbA 1 c was 7.83%, this value being the primary outcome in all cases (Adachi et al, ; Adolfsson, Walker‐Engström, Smide, & Wikblad, ; Clancy, Huang, Okonofua, Yeager, & Magruder, ; Davies et al, ; Deakin, Cade, Williams, & Greenwood, ; DePue et al, ; D'Eramo Melkus et al, ; Gregg, Callaghan, Hayes, & Glenn‐Lawson, ; Grillo et al, ; Hörnsten, Lundman, Stenlund, & Sandström, ; Houweling et al, ; Jutterström, Hörnsten, Sandström, Stenlund, & Isaksson, ; Khunti et al, ; Mash et al, ; Salinero‐Fort et al, ; Sönnichsen et al, ; Sturt et al, ; Thom et al, ; Wattana, Srisuphan, Pothiban, & Upchurch, ; Welch et al, ) except the Look AHEAD Study (Redmon et al, ), in which it was the weight loss achieved. The follow‐up periods ranged from 3–36 months, the most common being 12–14 months (13 studies).…”